Unlock a year of insightful reporting, innovative features, and expert analysis from award-winning reporters with a limited ...

The Law Offices of Frank R. Cruz announces an investigation of Hasbro, Inc. ("Hasbro" or the "Company") (NASDAQ: HAS) on behalf of investors concerning the Company's possible violations of federal ...

Morgan Stanley (NYSE: MS) announced today that it has won two Industry Awards from the Money Management Institute (MMI) and Barron's. The awards include a Wealth Manager Platform of The Year Award for ...

Today, the jury reached a verdict in favor of Monsanto in the Womack Roundup™ product liability trial before Judge Michael Erdos in the Philadelphia Court of Common Pleas. In response to the decision, ...

JSB Financial Inc. (OTCPink: JFWV) reported net income of $2.0 million for the quarter ended September 30, 2024, representing an increase of $1.3 million when compared to $643 thousand for the quarter ...

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming January 13, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of PACS Group, Inc. ("PACS Group" or ...

KBRA assigns preliminary ratings to five classes of notes issued by Thoma Bravo Credit Asset Funding, ABS, LLC ("TBCAF 2023-1R"), a cash flow collateralized debt obligation backed by a diversified ...

Virtual and in-person event, Bridging Basic Science and Liver Disease, brings together hundreds of leading biomedical ...

PITTSBURGH, Nov. 14, 2024 /PRNewswire/ -- "I wanted to create an innovative and distinctive way for vehicle owners to proudly ...

APEX, N.C., Nov. 14, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Robert John Lake is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for his contributions ...

Cybersecurity retains its place as the top-ranked risk and top area of audit effort: 82% of internal auditors rated this risk as "very high" or "higher than average" for their organizations in 2025, ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.